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Surgical Treatment of Induced Peri-
Implantitis in the Micro Pig: Clinical
and Histological Analysis
Gurbhajan Singh, * Robert B. O'Neal,^ William A. Brennan,x Scott L. Strong,§
Jack A. Horner,[l and Thomas E. Van Dyke1
The purpose of this pilot study was to determine if lost osseous support adjacent to
root form implants could be regenerated using a guided tissue regeneration technique.
Three fixtures were placed in each edentulous mandibular bicuspid region of two micro
pigs. A total of 6 fixtures were placed in each pig. Due to the presence of a pathologic
condition, which was in no way related to the research, the results of one pig were not
evaluated. Following osseointegration, peri-implantitis was induced by the use of liga-
tures and a soft diet. Three modalities of treatment were performed. Utilizing a surgical
flap approach, one third of the fixtures (one per quadrant) were covered with expanded
polytetrafluoroethylene (ePTFE) membrane and submerged under the soft tissue complex.
The second group of fixtures were submerged under the soft tissue complex with no
ePTFE membrane. The control fixtures along with their abutments were debrided and
remained non-submerged. All fixtures were debrided using an air-abrasive polishing
system. The osseous defects around the fixtures were measured from a fixed reference
point at the time of surgery and after obtaining block sections. At euthanasia, 12 weeks
after surgery, block sections of fixtures were removed, fixed, dehydrated, embedded,
sectioned, and prepared for SEM analysis. The clinical results showed a decrease in the
depth of osseous defects adjacent to fixtures submerged with a ePTFE membrane. There
was a gain of up to 5 mm of bone coronally (mean = 2.13 mm). Histologically, from
the base of the defect, 35.6% of the regenerated bone fill was osseointegrated, the
remaining 64.4% of the regenerated bone fill had a soft tissue interface between bone
and fixture. Fixtures that were submerged without an ePTFE membrane gained up to 3
mm of bone coronally (mean = 1.37 mm) with minimal osseointegration (7.8%). The
control specimens exhibited minimal gain in bone height (0.87 mm) with no osseointe-
gration. The data suggest that root form fixtures with peri-implantitis may be treated with
an ePTFE membrane covered by soft tissue. / Periodontol 1993 ¡64:984-989.
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Dental implants, especially the endosseous type, are be-
coming accepted as a routine option for replacing missing
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dentition.1 It is estimated that in 1992, 300,000 implants
were placed in the United States, and the number is ex-
pected to continue to increase in coming years.2 While data
on the incidence of implant failures are limited, bone loss
(peri-implantitis) around some osseointegrated fixtures has
been reported.3'4 The relationship between peri-implantitis
and plaque has not been fully researched. However, a num-
ber of studies have demonstrated that the microbiota asso-
ciated with stable and failing implants are similar to the
microbiota of periodontally healthy and diseased teeth,
respectively.4 9 If this is the situation, the periodontal com-
munity will play a major role in the maintenance of soft
tissue and osseous support around osseointegrated implants.
At the same time, failing implants that demonstrate pro-
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gressive bone loss will present a challenge to the periodon-
tist. Although information is available concerning clinical
treatment of the failing implant, little information can be
found which provides a histologie view of the healing that
has taken place.1017 Surgical techniques were employed in
case reports where the osseous defects were grafted with
demineralized cortical bone powder, demineralized freeze-
dried bone, and/or hydroxyapatite (40 to 60 mesh).10-11 These
studies reported only short-term follow-up and no histology
was available.
In recent years there has been considerable interest in the
concept of guided tissue regeneration (GTR), which is de-
signed to regenerate the lost attachment apparatus of peri-
odontally involved teeth.18-20 This principle was expanded
and applied in a series of experimental studies for the re-
generation of bone tissue in different types of jaw bone
defects, as well as around dental implants.21"24 In these
studies, a polytetrafluoroethylene (PTFE) membrane was
placed over the defect and closely adapted to the bone sur-
face surrounding the defect. Thus, a secluded space was
created between the bone defect and the inner surface of
the membrane into which cells originating from hard and
soft connective tissues could migrate without interference
from other competing tissue cell types. In association with
dental implants, GTR has a number of applications: 1) ridge
augmentation with subsequent placement of a fixture; 2)
immediate placement of fixtures following extractions; 3)
sinus lift procedures, either as a preparatory procedure for
placing fixtures at a later date or in conjunction with the
placement of fixtures; and 4) treating an osseous defect
associated with an osseointegrated fixture.
With limited understanding of the incidence and etiology
of peri-implantitis and treatment possibilities at hand, a study
was undertaken to determine if lost osseous support adja-
cent to root form fixtures* "could be regenerated using a
guided tissue regeneration technique.
MATERIALS AND METHODS
Twelve endosseous fixtures were inserted in the mandibular
bicuspid region of two micro pigs (3 bilaterally in each
pig).25'26 Following fixture osseointegration and abutment
placement, peri-implantitis was induced at 6 weeks by means
of silk ligatures and a soft diet. Osseous defects associated
with the peri-implantitis sites were confirmed clinically and
radiographically.
This protocol (DDEAMC 90-4) was approved by the In-
vestigational Review and Animal Use Committees at Dwight
David Eisenhower Army Medical Center, Fort Gordon,
Georgia.
The attending veterinarian administered the general an-
esthetics by using a combination of ketamine (20 mg/kg)
and xylozine (2.5 mg/kg) intramuscularly. General anes-
thesia was maintained using halothane (0.05-2.0%) corn-
Table 1. Time Frame for Labeling New Bone Formation
Day Dosage Drug
0 10 mg/kg Tetracycline HCl
14 10 mg/kg Tetracycline HCl
21 30 mg/kg Alizarin complexone
28 10 mg/kg Tetracycline HCl
42 10 mg/kg Tetracycline HCl
63 10 mg/kg Tetracycline HCl
bined with 50% nitrous oxide and oxygen with an endotra-
cheal tube in place.
Three treatment modalities were utilized to treat peri-
implantitis. All 3 groups received the following basic treat-
ment: 1) removing the abutment cylinders from the fixtures;
2) reflecting buccal and lingual mucoperiosteal flaps; 3)
notching the fixtures on 4 surfaces; 4) removing the gran-
ulation tissue from the defects; 5) recording measurements;
6) placing cover screws; and 7) debriding the fixture with
a forced air prophylaxis unit. The control group comprised
the sites located nearest to the cuspids. After basic treat-
ment, the cover screws were removed and abutment cyl-
inders were replaced.
In the Control Group, comprised of the 4 sites located
nearest to the cuspid, the soft tissue flaps were sutured into
position around the abutment cylinders.
Experimental Group 1 comprised the sites located be-
tween the Control and the Experimental Group 2 sites.
Treatment consisted of submerging the fixtures by covering
them with the soft tissue complex.
Experimental Group 2 comprised the sites nearest to the
molar. These sites were treated by placing an expanded
polytetrafluoroethylene (ePTFE) membrane** from which
the occlusive collar had been removed to cover the fixture
and bony surfaces from a level approximately 2 to 5 mm
apical to the bone crest in all directions, and submerging
the fixtures by covering the ePTFE membrane with the soft
tissue complex.
The surgical protocol included reflection of full thickness
flaps.27 Two parallel horizontal incisions were made joining
the 2 Experimental Group fixtures sites. Two vertical in-
cisions were then made, one at the distal of the Experi-
mental 2 site and the second in between Experimental 1
and Control fixture sites, to ensure that both the Experi-
mental 2 and Experimental 1 fixture sites were submerged.
A single horizontal incision extended from the vertical in-
cision between Experimental 1 and Control fixture sites and
extended to the mesial of the cuspid to join a third vertical
incision. Defects were measured from a point at the most
coronal extent of the fixture to the deepest point of the bony
defect on the buccal, lingual, and proximal surfaces of all
fixtures. At the time of surgery all fixtures had, at a min-
imum, the most concave surface below the second thread
exposed. The most coronal point of the fixtures were notched
#Nobelpharma, USA, Chicago, IL. "W.L. Gore and Associates, Flagstaff, AZ.
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Table 2. Comparison of Osseous Defect Measurements (in mm)*
Pre-Operative Post-Operative
Defect Defect Bone Gain
Group Depths Range Depths Range Height
Experimental 2 3.00 ± .92 2 to 5 0.87 ± 1.1 0 to 3 2.13
Experimentall 2.94 ± .49 2 to 3.5 1.56 ± 1.34 0 to 3 1.37
Control 3.75 ± .46 3 to 4.5 2.87 ± 0.83 2 to 4 0.87
* Measurements were taken at 4 notched areas (mesial, distal, facial, and lingual) on each implant.
Figure 1. Tetracycline and alizarin red complexone labeling of new bone adjacent to implant fixture 12 weeks
post treatment. A: first tetracycline line; B: alizarine red complexone at end of week 3x3.
with a surgical blade to aid in the reproducibility of the
measurement of the defects. Absorbable sutures were used
to close the surgical sites.
Tetracycline and alizarin red complexone were given in-
tramuscularly as previously described28 30 (Table 1) in an
effort to label any potential new bone formation.
After the initial 6-week healing period, the ePTFE mem-
brane was surgically removed from the Experimental Group
2 sites. At the end of the 12-week post-operative healing
period, the animals were sacrificed. The extent of the defect
fill associated with apposition of new bone was measured
from the landmarks on the fixtures with the following steps:
1) block sectioning; 2) reflection of the buccal and lingual
mucoperiosteal flaps; 3) removal of cover screws; 4) re-
cording measurements; and 5) the taking of radiographs.
During the postsurgical phase, clinical observations were
made at regular intervals and it was noted that one animal
exhibited an altered healing of the surgical sites. A diag-
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Figure 2. Comparison of the initial osseous defects and the percent of
osseointegration for the three groups.
nosis of marrow fibrosis throughout the mandible was made
by a veterinary pathologist. The samples from this animal
were then excluded from the results of this study leaving
only one pig and two samples for each measure.
Following sacrifice with T-61 euthanasia solution, the
specimens were fixed in 2% glutaraldehyde solution for at
least 24 hours followed by rinsing with a buffer. The spec-
Figure 3. Photomicrograph of experimental 2 fixture. A: most concave
point below second thread; B: most coronal point of re-osseointgration;
C: coronal height of new bone (original magnification x 33).
Figure 4. Photomicrograph of experimental 1 fixture. A: most concave
point below second thread; B: most coronal point of re-osseointgration;
C: coronal height of new bone (original magnification  27).
imens were cut into appropriate sizes for handling purposes.
The specimens were then dehydrated using 50%, 75%, and
95% ethanol each with 30-minute rinses followed by 100%
ethanol with 3 changes every 30 minutes. The specimens
were embedded in eponate-12 and polymerized for 24 hours
before being sawed with a diamond blade fitted on a Bueh-
ler Wafer saw. The final shape of the specimens thus ob-
tained were analyzed using the scanning electron micro-
scope and a digitizer.
The following methods of evaluation were used: 1) clin-
ical measurement analysis of the osseous defects before and
after the experimentation; 2) fluorescence analysis; and 3)
SEM analysis with quantitative measurement of re-osseoin-
tegration using the digitizer.
RESULTS
Pre- and post-experimental clinical measurements of the
osseous defects taken for the three treatment variables re-
vealed that the maximal gain in bone height was achieved
when the fixtures were covered with ePTFE membrane un-
der the soft tissue complex (Table 2). There was a gain of
up to 5 mm of bone coronally (mean = 2.13 mm) in Ex-
perimental 2 sites; a gain of up to 3 mm of bone coronally
(mean = 1.37 mm) in Experimental 1 sites, and a gain of
minimal bone height (0.87 mm) in Control sites. Because
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Figure 5. Photomicrograph of control fixture. A: Most concave point
below second thread; B: Most coronal point of re-osseointgration; C:
Coronal height of new bone (original magnification x 27).
of the small sample size, no statistical analysis was done
and this is recognized as a shortcoming of this study.
The sectioned samples were analyzed for tetracycline and
alizarin red complex band(s) under the fluorescence micro-
scope using the blue light of maximum intensity at 436 nm.
Figure 1 shows the various tetracycline bands and one al-
izarin red complex band of newly-formed bone at a site that
was previously diseased.
Quantitative measurement of osseointegration in the newly
formed "bone fill" sites was utilized using a Summagraph-
ics Digitizer and Sigma Scan Software. Enlarged photos
(8"  10") of the SEM sections ( x 27) were given to two
independent examiners (SLS and TEV) to demarcate the
re-osseointegrated areas. Both examiners demarcated the
areas in the photos where bone made direct contact with
the fixture surface(s). The most concave point below the
second thread was used as a baseline for the beginning of
re-osseointegration. Using the digitizer, the total length of
the re-osseointegrated site, as well as the total length of the
fixture surface that was previously diseased, was obtained.
The data from both examiners were averaged. The results
(Fig. 2) showed that in Experimental 2 sites, 35.6% of the
sectioned plane had new osseointegration in previously dis-
eased areas of the fixture (Fig. 3). In Experimental 1 sites,
only 7.8% of the sectioned plane had new osseointegration
(Fig. 4). In control sites, there was no new osseointegration
(Fig. 5).
DISCUSSION
This study evaluated the surgical treatment options and pro-
vides histological data associated with various methods used
to rescue failing implants. Keeping in mind the constraints
and limitations of this study, we found that endosseous
fixtures showing peri-implantitis may be treated success-
fully by draping an ePTFE membrane over the defect and
then submerging the entire ePTFE membrane and fixture
complex under the soft tissue. This may require coronal
positioning of the flap.
There are 3 ways to secure the ePTFE membrane. Sutures
may be used to secure the membrane to the connective
tissue surface of the flap. Alternatively, a hole may be made
in the ePTFE with a rubber dam punch; the membrane is
secured to the fixture by means of the cover screw. This
method may cause the membrane to bunch or not allow it
to drape the defect in the desired fashion. Finally, it may
not be necessary to secure the membrane in any fashion
other than the pressure exerted on it by the overlying soft
tissue flap. In this protocol, sutures were used to secure the
membrane in place.
While the etiology of failing implants varies, the diag-
nosis of a failed implant is not complicated. Probing depths
and radiographs should be used routinely as diagnostic aids
to assist in the diagnosis of failing implants. Even though
various studies have looked at the microbiology of failing
implants, we still lack information concerning the incidence
and causes of peri-implantitis. It would seem that our results
might offer a viable treatment option. Again, however, the
limitations of this study must be emphasized. This was a
small pilot study initially using two micro pigs. The results
from one of these animals were not evaluated due to a
systemic pathologic aberration which was not associated
with the research in any way. It should also be mentioned
that, since the sites were not randomly assigned, the results
seen could have been due to the location of the treatment
rather than the treatment itself. Due to the small sample
size, no hypothesis testing could be done which, of course,
limits the inferences that can be drawn from this type of
study.
Conclusion
The data suggest that root form fixtures with peri-implan-
titis may be treated with an ePTFE membrane covered by
soft tissue. However, areas of new clinical bone fill were
not totally osseointegrated, as evidenced by the histologie
finding of a soft tissue interface between bone and fixture
in some areas of all specimens. The amount of new clinical
bone that was osseointegrated, however, correlates well with
the finding of Hale et al.,31 who found a mean bone contact
of 35% in micropigs after 4V2 months of healing following
initial fixture placement in healthy sites. This pilot study
shows the possibility of treatment of failing implants with
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ePTFE membranes, but demonstrates the need for further
work in this area.
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